[New drug formulations as the result of recent technological development efforts].
D000085:Acetates; D000818:Animals; D000941:Antigens / Q000008:administration & dosage; D002214:Capsules; D002482:Cellulose; D003692:Delayed-Action Preparations; D004339:Drug Compounding; D004655:Emulsions; D005782:Gels; D006863:Hydrogen-Ion Concentration; D007074:Immunoglobulin G / Q000008:administration & dosage; D007279:Injections, Subcutaneous; D008055:Lipids; D009994:Osmolar Concentration; D010615:Phenacetin / Q000008:administration & dosage; D010710:Phosphates; D010795:Phthalic Acids; D011108:Polymers; D012964:Sodium; D012995:Solubility; D013431:Sulfates; D013535:Suspensions; D013552:Swine; D013997:Time Factors
D000085:Acetates; D000941:Antigens; D002214:Capsules; D003692:Delayed-Action Preparations; D004655:Emulsions; D005782:Gels; D007074:Immunoglobulin G; D008055:Lipids; D010710:Phosphates; D010795:Phthalic Acids; D011108:Polymers; D013431:Sulfates; D013535:Suspensions; D002482:Cellulose; D012964:Sodium; D010615:Phenacetin
Neue Arzneiformen als Resultat rezenter technologischer Entwicklungsarbeiten.